Interactions Between Cocaine and Ethanol and Disulfiram - 1
Sponsor
National Institute on Drug Abuse (NIDA) (NIH)
Overall Status
Unknown status
CT.gov ID
NCT00094289
Collaborator
(none)
16
2
11
8
0.7
Study Details
Study Description
Brief Summary
The purpose of this study is to assess potential interactions between intravenous cocaine and ethanol and oral disulfiram.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
Phase 1 |
Detailed Description
This is a two-site, double blind, placebo-controlled inpatient study to determine the cardiovascular and psychiatric safety of alcohol use in cocaine-dependent subjects who had used cocaine after treatment with disulfiram.
Study Design
Study Type:
Interventional
Primary Purpose:
Treatment
Official Title:
Interactions Between IV Cocaine and Ethanol and Oral Disulfiram
Study Start Date
:
Aug 1, 2004
Study Completion Date
:
Jul 1, 2005
Outcome Measures
Primary Outcome Measures
- Safety assessments []
- Psychological effects []
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 50 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Must meet DSM-4 criteria for cocaine abuse or dependence and are not seeking treatment.
-
Ability to verbalize understanding of consent form and provide written informed consent and verbalize willingness to complete study procedures; be able to comply with protocol requirements.
Exclusion Criteria:
- Please contact site for more information.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | UCLA Integrated Substance Abuse Program | Los Angeles | California | United States | 90024 |
2 | University of Texas Hlth Sci Ctr San Ant | San Antonio | Texas | United States | 78284 7828 |
Sponsors and Collaborators
- National Institute on Drug Abuse (NIDA)
Investigators
- Principal Investigator: John Roache, Ph.D., University of Texas Health Sci Cntr, San Antonio
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00094289
Other Study ID Numbers:
- NIDA-MDS-0003-1
First Posted:
Oct 15, 2004
Last Update Posted:
Jan 11, 2017
Last Verified:
Jul 1, 2005
Additional relevant MeSH terms: